Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004030104 | SCV004063490 | uncertain significance | not specified | 2023-07-31 | criteria provided, single submitter | clinical testing | The c.3491C>T (p.P1164L) alteration is located in exon 35 (coding exon 34) of the RNF123 gene. This alteration results from a C to T substitution at nucleotide position 3491, causing the proline (P) at amino acid position 1164 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genetics and Genomics Program, |
RCV001199398 | SCV001134949 | uncertain significance | Hypertrophic cardiomyopathy | no assertion criteria provided | research |